{"id":6477,"date":"2018-11-25T09:04:00","date_gmt":"2018-11-25T09:04:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&#038;p=6477"},"modified":"2024-05-02T11:14:31","modified_gmt":"2024-05-02T09:14:31","slug":"p154-clinical-assessment-of-prognosis-and-the-prognostic-factors-in-intestinal-bahcets-disease","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/fr\/professional\/scientific-corner\/p154-clinical-assessment-of-prognosis-and-the-prognostic-factors-in-intestinal-bahcets-disease\/","title":{"rendered":"P154 Clinical assessment of prognosis and the prognostic factors in intestinal Behcet\u2019s disease"},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"javascript:;\">M Hachiya<\/a>,&nbsp;<a href=\"javascript:;\">T Sakurai<\/a>,&nbsp;<a href=\"javascript:;\">Y Nagata<\/a>,&nbsp;<a href=\"javascript:;\">A Hidaka<\/a>,&nbsp;<a href=\"javascript:;\">Y Akita<\/a>,&nbsp;<a href=\"javascript:;\">H Miyashita<\/a>,&nbsp;<a href=\"javascript:;\">Y Maruyama<\/a>,&nbsp;<a href=\"javascript:;\">R Miyazaki<\/a>,&nbsp;<a href=\"javascript:;\">M Noguchi<\/a>,&nbsp;<a href=\"javascript:;\">R Sawada<\/a>,&nbsp;<a href=\"javascript:;\">J Mitobe<\/a>,&nbsp;<a href=\"javascript:;\">M Mitsunaga<\/a>,&nbsp;<a href=\"javascript:;\">T Yamasaki<\/a>,&nbsp;<a href=\"javascript:;\">T Kato<\/a>,&nbsp;<a href=\"javascript:;\">M Saruta<\/a>, <em>Journal of Crohn&rsquo;s and Colitis<\/em>, Volume 12, Issue supplement_1, February 2018,<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>Approximately 30% of all cases and 50% of severe cases that had received biologics were not able to avoid surgery. In severe cases, it is important to evaluate early treatment efficacy and prognostic factors because the median time of administration of biologics was only 9 weeks. However, no independent prognostic factor was found in this study.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/academic.oup.com\/ecco-jcc\/article\/12\/supplement_1\/S173\/4808214\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/academic.oup.com\/ecco-jcc\/article\/12\/supplement_1\/S173\/4808214<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>M Hachiya,&nbsp;T Sakurai,&nbsp;Y Nagata,&nbsp;A Hidaka,&nbsp;Y Akita,&nbsp;H Miyashita,&nbsp;Y Maruyama,&nbsp;R Miyazaki,&nbsp;M Noguchi,&nbsp;R Sawada,&nbsp;J Mitobe,&nbsp;M Mitsunaga,&nbsp;T Yamasaki,&nbsp;T Kato,&nbsp;M Saruta, Journal of Crohn&rsquo;s and Colitis, Volume 12, Issue supplement_1, February 2018, Approximately 30% of all cases and 50% of severe cases that had received biologics were not able to avoid surgery. In severe cases, it is important to evaluate [&hellip;]<\/p>\n","protected":false},"template":"","scientific_tags":[203,457,460,271],"class_list":["post-6477","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-behcets-disease","scientific_tags-biological-products","scientific_tags-prognosis","scientific_tags-study"],"acf":{"sc_authors":"<a href=\"https:\/\/academic.oup.com\/ecco-jcc\/article\/12\/supplement_1\/S173\/4808214\">https:\/\/academic.oup.com\/ecco-jcc\/article\/12\/supplement_1\/S173\/4808214<\/a>"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>P154 Clinical assessment of prognosis and the prognostic factors in intestinal Behcet\u2019s disease - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/p154-clinical-assessment-of-prognosis-and-the-prognostic-factors-in-intestinal-bahcets-disease\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"P154 Clinical assessment of prognosis and the prognostic factors in intestinal Behcet\u2019s disease - Adacyte\" \/>\n<meta property=\"og:description\" content=\"M Hachiya,&nbsp;T Sakurai,&nbsp;Y Nagata,&nbsp;A Hidaka,&nbsp;Y Akita,&nbsp;H Miyashita,&nbsp;Y Maruyama,&nbsp;R Miyazaki,&nbsp;M Noguchi,&nbsp;R Sawada,&nbsp;J Mitobe,&nbsp;M Mitsunaga,&nbsp;T Yamasaki,&nbsp;T Kato,&nbsp;M Saruta, Journal of Crohn&rsquo;s and Colitis, Volume 12, Issue supplement_1, February 2018, Approximately 30% of all cases and 50% of severe cases that had received biologics were not able to avoid surgery. In severe cases, it is important to evaluate [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/p154-clinical-assessment-of-prognosis-and-the-prognostic-factors-in-intestinal-bahcets-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-02T09:14:31+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/p154-clinical-assessment-of-prognosis-and-the-prognostic-factors-in-intestinal-bahcets-disease\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/p154-clinical-assessment-of-prognosis-and-the-prognostic-factors-in-intestinal-bahcets-disease\/\",\"name\":\"P154 Clinical assessment of prognosis and the prognostic factors in intestinal Behcet\u2019s disease - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2018-11-25T09:04:00+00:00\",\"dateModified\":\"2024-05-02T09:14:31+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/p154-clinical-assessment-of-prognosis-and-the-prognostic-factors-in-intestinal-bahcets-disease\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"P154 Clinical assessment of prognosis and the prognostic factors in intestinal Behcet\u2019s disease - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/p154-clinical-assessment-of-prognosis-and-the-prognostic-factors-in-intestinal-bahcets-disease\/","og_locale":"fr_FR","og_type":"article","og_title":"P154 Clinical assessment of prognosis and the prognostic factors in intestinal Behcet\u2019s disease - Adacyte","og_description":"M Hachiya,&nbsp;T Sakurai,&nbsp;Y Nagata,&nbsp;A Hidaka,&nbsp;Y Akita,&nbsp;H Miyashita,&nbsp;Y Maruyama,&nbsp;R Miyazaki,&nbsp;M Noguchi,&nbsp;R Sawada,&nbsp;J Mitobe,&nbsp;M Mitsunaga,&nbsp;T Yamasaki,&nbsp;T Kato,&nbsp;M Saruta, Journal of Crohn&rsquo;s and Colitis, Volume 12, Issue supplement_1, February 2018, Approximately 30% of all cases and 50% of severe cases that had received biologics were not able to avoid surgery. In severe cases, it is important to evaluate [&hellip;]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/p154-clinical-assessment-of-prognosis-and-the-prognostic-factors-in-intestinal-bahcets-disease\/","og_site_name":"Adacyte","article_modified_time":"2024-05-02T09:14:31+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/p154-clinical-assessment-of-prognosis-and-the-prognostic-factors-in-intestinal-bahcets-disease\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/p154-clinical-assessment-of-prognosis-and-the-prognostic-factors-in-intestinal-bahcets-disease\/","name":"P154 Clinical assessment of prognosis and the prognostic factors in intestinal Behcet\u2019s disease - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2018-11-25T09:04:00+00:00","dateModified":"2024-05-02T09:14:31+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/p154-clinical-assessment-of-prognosis-and-the-prognostic-factors-in-intestinal-bahcets-disease\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner\/6477","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/media?parent=6477"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific_tags?post=6477"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}